Showing results (31-40 of 75) with videos related to
Sort By:
Pageof 8
Cancer Genomics & Proteomics|August 29, 2023
H19 in Serum Extracellular Vesicles Reflects Resistance to AR Axis-targeted Therapy Among CRPC PatientsTaku Kato, Kyojiro Kawakami, Kosuke Mizutani, et al.Cancer Reports (Hoboken, N.J.)|November 11, 2020
Preoperative predictive factors of carcinoma in situ in the normal-appearing mucosa in patients who underwent an initial transurethral resection for non-muscle-invasive bladder cancer under white light cystoscopyKoji Iinuma, Kazuya Yuhara, Hiroto Kotaka, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 3, 2017
Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in JapanTakashi Deguchi, Shin Ito, Mitsuru Yasuda, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 17, 2017
Clinical courses of herpes simplex virus-induced urethritis in menShin Ito, Mitsuru Yasuda, Hiromi Kondo, et al.Oncology|July 30, 2020
Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological FeaturesKengo Horie, Kyojiro Kawakami, Yasunori Fujita, et al.Hinyokika Kiyo. Acta Urologica Japonica|September 11, 2019
[Cardiac Metastasis in a Patient with Clear Cell Renal Cell Carcinoma who Underwent Multimodality Therapy for Multiple Metastases after Radical Nephrectomy]Shinichi Takeuchi, Kosuke Mizutani, Koji Iinuma, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 16, 2017
GyrA and/or ParC alterations of Haemophilus influenzae strains isolated from the urethra of men with acute urethritisHiromi Kondo, Shin Ito, Kyoko Hatazaki, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 9, 2018
Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatisTakashi Deguchi, Kyoko Hatazaki, Shin Ito, et al.Cytokine|July 24, 2013
CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signalingTaku Kato, Yasunori Fujita, Keita Nakane, et al.Neoplasia (New York, N.Y.)|November 3, 2009
The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitmentKosuke Mizutani, Sudha Sud, Natalie A McGregor, et al.Pageof 8